Experimental Evidence for the Involvement of PDLIM5 in Mood Disorders in Hetero Knockout Mice

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Horiuchi, Yasue ^a   Ishikawa, Maya ^a   Kaito, Nobuko ^a   Iijima, Yoshimi ^a   Tanabe, Yoshiko ^a   Ishiguro, Hiroki ^a   Arinami, Tadao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; IMIPRAMINE; MESSENGER RNA; METHAMPHETAMINE; NUCLEIC ACID BINDING PROTEIN; PDZ LIM DOMAIN 5 PROTEIN; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN; CHRONIC DISEASE; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; EMBRYO DEATH; FORCED SWIMMING TEST; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HOMOZYGOSITY; HYPERACTIVITY; IMMOBILIZATION; LOCOMOTION; MALE; MANIA; MOOD DISORDER; MOUSE; NONHUMAN; PATHOGENESIS; PDLIM5 GENE; PREFRONTAL CORTEX; PREPULSE INHIBITION; STARTLE REFLEX; TONIC IMMOBILITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; BRAIN; CELL LINE; DEPRESSIVE DISORDER; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HALOPERIDOL; IMIPRAMINE; INHIBITION (PSYCHOLOGY); LIM DOMAIN PROTEINS; MALE; METHAMPHETAMINE; MICE; MICROFILAMENT PROTEINS; MOTOR ACTIVITY; PEPTIDES; PROTEIN KINASE C-EPSILON; PROTEIN TRANSPORT; STARTLE REACTION; SWIMMING;

MUS;

EID: 84876007458     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059320     Document Type: Article

References (51)

1. Kuroda S, Tokunaga C, Kiyohara Y, Higuchi O, Konishi H, et al. (1996) Protein-protein interaction of zinc finger LIM domains with protein kinase C. J Biol Chem. 271: 31029-31032.
2. Niederlander N, Fayein NA, Auffray C, Pomies P, (2004) Characterization of a new human isoform of the enigma homolog family specifically expressed in skeletal muscle. Biochem Biophys Res Commun 325: 1304-1311.
3. Ueki N, Seki N, Yano K, Masuho Y, Saito T, et al. (1999) Isolation, tissue expression, and chromosomal assignment of a human LIM protein gene, showing homology to rat enigma homologue (ENH). J Hum Genet 44: 256-260.
4. Maeno-Hikichi Y, Chang S, Matsumura K, Lai M, Lin H, et al. (2003) A PKC epsilon-ENH-channel complex specifically modulates N-type Ca2+ channels. Nat Neurosci 6: 468-475.
5. Maturana AD, Nakagawa N, Yoshimoto N, Tatematsu K, Hoshijima M, et al. (2011) LIM domains regulate protein kinase C activity: a novel molecular function. Cell Signal 23: 928-934.
6. Gardezi SR, Weber AM, Li Q, Wong FK, Stanley EF (2009) PDLIM5 is not a neuronal CaV2.2 adaptor protein. Nat Neurosci 12: 957-958; author reply 958.
7. Herrick S, Evers DM, Lee JY, Udagawa N, Pak DT, (2009) Postsynaptic PDLIM5/Enigma Homolog binds SPAR and causes dendritic spine shrinkage. Mol Cell Neurosci 43: 188-200.
8. Chen Y, Lai M, Maeno-Hikichi Y, Zhang JF, (2006) Essential role of the LIM domain in the formation of the PKCepsilon-ENH-N-type Ca2+ channel complex. Cell Signal 18: 215-224.
9. Horiuchi Y, Arai M, Niizato K, Iritani S, Noguchi E, et al. (2006) A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia. Biol Psychiatry 59: 434-439.
10. Kato T, Iwayama Y, Kakiuchi C, Iwamoto K, Yamada K, et al. (2005) Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia. Mol Psychiatry 10: 1045-1055.
11. Li C, Tao R, Qin W, Zheng Y, He G, et al. (2008) Positive association between PDLIM5 and schizophrenia in the Chinese Han population. Int J Neuropsychopharmacol 11: 27-34.
12. Shi J, Badner JA, Liu C, (2008) PDLIM5 and susceptibility to bipolar disorder: a family-based association study and meta-analysis. Psychiatr Genet 18: 116-121.
13. Squassina A, Manchia M, Manconi F, Piccardi M, Ardau R, et al. (2008) A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample. Psychiatr Genet 18: 128-132.
14. Liu Z, Liu W, Xiao Z, Wang G, Yin S, et al. (2008) A major single nucleotide polymorphism of the PDLIM5 gene associated with recurrent major depressive disorder. J Psychiatry Neurosci 33: 43-46.
15. Wong ML, Dong C, Andreev V, Arcos-Burgos M, Licinio J, (2012) Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors. Mol Psychiatry 17: 624-633.
16. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, et al. (2007) Gene expression in the peripheral leukocytes and association analysis of PDLIM5 gene in schizophrenia. Neurosci Lett 415: 28-33.
17. Iga J, Ueno S, Yamauchi K, Numata S, Motoki I, et al. (2006) Gene expression and association analysis of LIM (PDLIM5) in major depression. Neurosci Lett 400: 203-207.
18. Consortium WTCC, (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
19. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T (2004 a) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9: 406-416.
20. Zain MA, Jahan SN, Reynolds GP, Zainal NZ, Kanagasundram S, et al. (2012) Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration. BMC Med Genet 13: 91.
21. Shelton RC, Hal Manier D, Lewis DA, (2009) Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls. Int J Neuropsychopharmacol 12: 1223-1232.
22. Wang HY, Friedman E, (1996) Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 40: 568-575.
23. Friedman E, Wang HY, (1996) Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J Neurochem 67: 1145-1152.
24. Hahn CG, Friedman E, (1999) Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1: 81-86.
25. Wang HY, Markowitz P, Levinson D, Undie AS, Friedman E, (1999) Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. J Psychiatr Res 33: 171-179.
26. Hahn CG, Umapathy, Wang HY, Koneru R, Levinson DF, et al. (2005) Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 39: 355-363.
27. Pandey GN, Ren X, Dwivedi Y, Pavuluri MN, (2008) Decreased protein kinase C (PKC) in platelets of pediatric bipolar patients: effect of treatment with mood stabilizing drugs. J Psychiatr Res 42: 106-116.
28. Chen G, Manji HK, Hawver DB, Wright CB, Potter WZ, (1994) Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem 63: 2361-2364.
29. Friedman E, Hoau Yan W, Levinson D, Connell TA, Singh H, (1993) Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 33: 520-525.
30. Manji HK, Etcheberrigaray R, Chen G, Olds JL, (1993) Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme. J Neurochem 61: 2303-2310.
31. Manji HK, Lenox RH, (1999) Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46: 1328-1351.
32. Young LT, Wang JF, Woods CM, Robb JC, (1999) Platelet protein kinase C alpha levels in drug-free and lithium-treated subjects with bipolar disorder. Neuropsychobiology 40: 63-66.
33. Shilling PD, Kuczenski R, Segal DS, Barrett TB, Kelsoe JR, (2006) Differential regulation of immediate-early gene expression in the prefrontal cortex of rats with a high vs low behavioral response to methamphetamine. Neuropsychopharmacology 31: 2359-2367.
34. Coccurello R, Caprioli A, Ghirardi O, Virmani A, (2007) Valproate and acetyl-L-carnitine prevent methamphetamine-induced behavioral sensitization in mice. Ann N Y Acad Sci 1122: 260-275.
35. da-Rosa DD, Valvassori SS, Steckert AV, Ornell F, Ferreira CL, et al. (2012) Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH. Psychiatry Res 198: 521-526.
36. Feier G, Valvassori SS, Varela RB, Resende WR, Bavaresco DV, et al. (2012) Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine. Pharmacol Biochem Behav 103: 589-596.
37. Johnson JA, Gray MO, Chen CH, Mochly-Rosen D, (1996) A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271: 24962-24966.
38. Przyklenk K, Li G, Simkhovich BZ, Kloner RA, (2003) Mechanisms of myocardial ischemic preconditioning are age related: PKC-epsilon does not play a requisite role in old rabbits. J Appl Physiol 95: 2563-2569.
39. Geyer MA Dulawa SC (2003) Assessment of murine startle reactivity, prepulse inhibition, and habituation. Current Protocols in Neuroscience. Chapter 8.17.
40. Powell SB, Zhou X, Geyer MA, (2009) Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res 204: 282-294.
41. Kohl S, Heekeren K, Klosterkotter J, Kuhn J (2012) Prepulse inhibition in psychiatric disorders- Apart from schizophrenia. J Psychiatr Res.
42. Koga M, Ishiguro H, Yazaki S, Horiuchi Y, Arai M, et al. (2009) Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. Hum Mol Genet 18: 2483-2494.
43. Syu A, Ishiguro H, Inada T, Horiuchi Y, Tanaka S, et al. (2010) Association of the HSPG2 Gene with Neuroleptic-Induced Tardive Dyskinesia. Neuropsychopharmacology 35: 1155-1164.
44. Nakagawa N, Hoshijima M, Oyasu M, Saito N, Tanizawa K, et al. (2000) ENH, containing PDZ and LIM domains, heart/skeletal muscle-specific protein, associates with cytoskeletal proteins through the PDZ domain. Biochem Biophys Res Commun 272: 505-512.
45. Maturana AD, Walchli S, Iwata M, Ryser S, Van Lint J, et al. (2008) Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel. Cardiovasc Res 78: 458-465.
46. Ott EB, Sakalis PA, Marques IJ, Bagowski CP, (2007) Characterization of the Enigma family in zebrafish. Dev Dyn 236: 3144-3154.
47. Iwamoto K, Bundo M, Washizuka S, Kakiuchi C, Kato T (2004 b) Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J Hum Genet 49: 227-231.
48. Malberg JE, (2004) Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci 29: 196-205.
49. Dawirs RR, Hildebrandt K, Teuchert-Noodt G, (1998) Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus. J Neural Transm 105: 317-327.
50. Keilhoff G, Grecksch G, Bernstein HG, Roskoden T, Becker A, (2010) Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur Arch Psychiatry Clin Neurosci 260: 151-162.
51. Lasorella A, Iavarone A, (2006) The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system. Proc Natl Acad Sci U S A 103: 4976-4981.